Does Alzheimer’s Disease with Early Onset Progress Faster than with Late Onset? A Case-Control Study of Clinical Progression and Cerebrospinal Fluid Biomarkers

Publisher： Karger

E-ISSN： 1421-9824|33|2-3|111-117

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.33, Iss.2-3, 2012-04, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Biomarkers in Clinical Subtypes of Early-Onset Alzheimer's Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 37, Iss. 5-6, 2013-12 ,pp. : 307-314

Karger

Access to resources Recommend Favorite

Apolipoprotein E Genotype in Sporadic Early- and Late-Onset Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-04 ,pp. : 121-125

Karger

Access to resources Recommend Favorite

Neuropsychological Performance and Conversion to Alzheimer’s Disease in Early- Compared to Late-Onset Amnestic Mild Cognitive Impairment: CREDOS Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 3-4, 2012-10 ,pp. : 156-166

Karger

Access to resources Recommend Favorite

Folate and Homocysteine in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease or Dementia: A Case Control Study

By  

European Neurology, Vol. 65, Iss. 5, 2011-04 ,pp. : 270-278

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 1, 2012-02 ,pp. : 1-5

Karger

Access to resources Recommend Favorite